Literature DB >> 16930090

Gerontology forum: an update on the literature.

.   

Abstract

New treatments and treatment protocols for diseases affecting the elderly are evolving as we strive to meet the needs of an aging society. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy and patient management, this section of the journal brings you information selected from the rapid drug news alerting service Inpharma Weekly. Each issue contains easy-to-read summaries of the most important research and development news, clinical studies, treatment guidelines, and pharmacoeconomic news.

Entities:  

Mesh：

Year:  2006        PMID： 16930090     DOI： 10.2165/00002512-200623070-00008

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


  16 in total

1.  L-carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly.

Authors:  Mariano Malaguarnera; Antonino Di Mauro; Pia Maria Gargante; Liborio Rampello
Journal:  South Med J       Date:  2006-03       Impact factor: 0.954

2.  Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.

Authors:  Wolfgang H Oertel; Erik Wolters; Cristina Sampaio; Santiago Gimenez-Roldan; Bruno Bergamasco; Max Dujardin; Donald G Grosset; Guy Arnold; Klaus L Leenders; Hans-Peter Hundemer; Alberto Lledó; Andrew Wood; Paul Frewer; Johannes Schwarz
Journal:  Mov Disord       Date:  2006-03       Impact factor: 10.338

3.  Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.

Authors:  Katia Noyes; Hangsheng Liu; Yue Li; Robert Holloway; Andrew W Dick
Journal:  Mov Disord       Date:  2006-03       Impact factor: 10.338

4.  Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Authors:  Peter Johannsen; Eric Salmon; Harald Hampel; Yikang Xu; Sharon Richardson; Suzanne Qvitzau; Rachel Schindler
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.

Authors:  Werner Poewe; Erik Wolters; Murat Emre; Marco Onofrj; Chuanchieh Hsu; Sibel Tekin; Roger Lane
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

6.  Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

Authors:  Bengt Winblad; Lena Kilander; Sture Eriksson; Lennart Minthon; Stellan Båtsman; Anna-Lena Wetterholm; Catarina Jansson-Blixt; Anders Haglund
Journal:  Lancet       Date:  2006-04-01       Impact factor: 79.321

7.  Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.

Authors:  Yoshinori Nishino; Takako Masue; Kousei Miwa; Yoshito Takahashi; Satoshi Ishihara; Takashi Deguchi
Journal:  BJU Int       Date:  2006-04       Impact factor: 5.588

Review 8.  The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

Authors:  Rachael L DiSantostefano; Andrea K Biddle; John P Lavelle
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

9.  Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

Authors:  Elena Birman-Deych; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

10.  Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.

Authors:  Elaine M Hylek; James D'Antonio; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.